Global Biopreservation Market - Trends, Growth and Forecasts 2017 - 2022

  • ID: 4388569
  • Report
  • Region: Global
  • 211 pages
  • Mordor Intelligence
1 of 3
The global biopreservation market is estimated to reach USD 2223.7 million by the end of 2016. Considering the current market status, growth indicator and expected future trends, the market is estimated to reach USD 3312.9 billion by 2021, growing at a CAGR of 8.3% during the forecast period.

The global biopreservation market study report comprises of worldwide biopreservation market information such as market size, value, and forecasts. It offers an extensive analysis of every segment of the market in major regions across the globe. In addition to the market estimation, the report throws light on the competitive landscape, as well. Moreover, the study documents company profiles of all the major market players, comprising of their business strategy and SWOT analysis, etc. The key offerings and elaborative report structure are specified in the description that follows.

Market Dynamics: Drivers and Restraints

Improving healthcare expenditure around the world, advancements in research and development, adoption of in-house sample storage in hospitals and labs, and investments in bio-banks and personalized medicine are some of the factors driving the market for biopreservation. However, the high cost of instruments and their maintenance and possibility of tissue injury during preservation and thawing are a few major restraining factors hindering the growth of the market.

Market Segmentation

The global biopreservation market is segmented into:

Type of Products





The product segment is further divided on the basis of biopreservation media (nutrient media, sera, and other supplements) and equipment (temperature maintaining units- freezers, cryogenic storage systems, thawing equipment, refrigerators, and centrifuges). The end-user segment is sub-segmented into biobanks, gene banks, and hospitals. The application segment is divided into therapeutics, research, clinical trials and others. Further, the market is also segmented into various services such as biobanking for individuals (umbilical cord/stem cell banking, ovum/egg banking), and biobanking for institutes (tissue banking, cell banking services, organ banking, and repository services).

Geographically, the market is segmented into North America (the USA, Canada and Mexico), Europe (Germany, the UK, France, Italy, Spain & Portugal, Scandinavia, BENELUX), Asia-Pacific (China, Japan, India, Australia and New Zealand, South Korea), the Middle East and Africa (GCC, South Africa) and Latin America (Brazil and Argentina).

Latin America is expected to experience the highest growth rate during the forecast period; while, regarding market value, the North American region will hold the largest amount during the next five years. Emerging markets are expected to grow at a higher CAGR than industrialized nations during the forecast period of 2016 to 2021, due to growing investments in research, increasing expenditure on healthcare, and rising awareness about biobanking.

Key Players in the Biopreservation Market

Key Deliverables:

Market analysis for the global biopreservation market, with region specific assessments and competition analysis.

Market definition along with the identification of key drivers, restraints opportunities and challenges.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.

Identification and analysis of the macro and micro factors that affect the global biopreservation market.

Insights of the market in the regions that have the highest potential for growth and also identify the markets that are still untapped.
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Study Deliverables
1.2 Market Definition
1.3 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Methodology
2.3 Study Timeleine
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering and Econometric Modelling
2.4.4 Expert Validation
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
5.1 Current Market Scenario
5.2 New Developments
5.3 Porter's Five Forces
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Intensity of Competitive Rivalry
5.3.4 Threat of Substitute Product and Services
5.3.5 Threat of New Entrants
6. Drivers, Restraints, Opportunities, and Challenges Analysis
6.1 Market Drivers
6.1.1 Improving Healthcare Expenditure
6.1.2 Increasing Advancements in Research and Development
6.1.3 Adoption of In-House Sample Storage in Hospitals and Labs
6.1.4 Investments in Biobanks and Personalized Medicine
6.2 Market Restraints
6.2.1 High Cost of the Instruments and its Maintenance
6.2.2 Possibility of Tissue Injury During Preservation and Thawing
6.3 Key Challenges
6.3.1 Ethical Issues:
6.3.2 Continuous Funding:
6.3.3 Sample Integrity and Data Management:
6.4 Current Opportunities in the Market
6.4.1 Personalized Medicine
6.4.2 In-Vitro Fertilization
7. Global Biopreservation Market Segmentation
7.1 By Product
7.1.1 By Biopreservation Media Nutrient Media Sera Other Supplements
7.1.2 By Equipment Temperature Maintaining Units Freezers Cryogenic Storage Systems: Thawing Equipment Refrigerators Centrifuges Others
7.2 By End-User
7.2.1 Biobanks
7.2.2 Gene Bank
7.2.3 Hospitals
7.2.4 Others
7.3 By Application
7.3.1 Therapeutics
7.3.2 Research
7.3.3 Clinical Trials
7.3.4 Others
8. Global Biopreservation Market - Segmentation, By Services
8.1 Biobanking for Individuals
8.1.1 Umbilical Cord/Stem Cell Banking
8.1.2 Ovum/ Egg Banking
8.1.3 Sperm Banking
8.1.4 Biobanking for Institutions
8.1.5 Tissue Banking
8.1.6 Cell Banking Service
8.1.7 Organ Banking
8.1.8 Repository Services
9. By Geography
9.1 North America
9.1.1 United States of America
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 United Kingdom
9.2.2 France
9.2.3 Germany
9.2.4 Spain & Portugal
9.2.5 Italy
9.2.6 Scandinavia
9.3 Asia-Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Australia and New Zealand
9.4 Latin America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Rest of Latin America
9.5 The Middle East and Africa (MEA)
9.5.1 GCC
9.5.2 South Africa
9.5.3 Rest of MEA
10. Competitive Landscape:
10.1 Agreements, Collaborations and Partnerships
10.2 Mergers & Acquisitions
10.3 New Product Launches
11. Key Vendor Analysis
11.1 Biolife Solutions Inc
11.2 Cesca Therapeutics Inc
11.3 Lifeline Scientific Inc
11.4 Sigma-Aldrich Corporation
11.5 Biocision Llc
11.6 Custom Biogenic Systems Inc
11.7 Chart Industries Inc
11.8 Hamilton Company
11.9 Simport Scientific
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown